US FDA Doesn’t Budge On ‘ACNU’ Switch Requirements Questioned By OTC Industry

Agency’s proposal for targeting making more formulations available nonprescription through “novel switches” went through changes on its path from idea in 2012 to proposed rule in 2022 and final rule published in December.